Discover funding opportunities for healthcare innovation, offering valuable support for collaborative projects. Explore our list below, regularly updated with new options. Connect with us at fundingsupport@lshubwales.com for guidance, bid writing assistance, and finding the perfect match for your innovation.
Grants to support the translational development of research that will advance novel therapeutics (excluding medical devices) for the treatment of hearing disorders and tinnitus.
Aims to support and accelerate the translation of research discoveries into potential new treatments to protect and restore hearing and/or silence tinnitus. It funds projects at both academic institutions and small/medium enterprises in any country.
Specifically, this funding opportunity aspires to train a new contingent of engineering biologists with advanced skills to further our understanding and to conduct research which addresses discovery-inspired challenges.
This call is a pan-European research infrastructure in structural biology and projects can be submitted in the area of development of 'AI tools for Integrated Structural Biology'.
Funding for research projects to accelerate the discovery and development of novel and innovative approaches likely to lead to improvements in the diagnosis and treatment of cancers affecting children, teenagers and young adults.
This will fund disciplines relevant to drug discovery and mental health science, including, but not limited to, genomics, computational psychiatry, molecular biology in psychiatry, medical chemistry, neuropharmacology, in-vitro/vivo/silico pharmacology and drug discovery.
Support for validation activities for novel targets with a clear therapeutic concept and strong biological rationale related to early intervention in anxiety, depression and/or psychosis.
MRC welcome applications from across all areas of our remit to improve human health. This may range from basic studies with relevance to mechanisms of disease, to translational and developmental clinical research, basic studies with relevance to mechanisms of disease, to translational and developmental clinical research.
This award is designed primarily to assist newly employed university lecturers, researchers in research council institutes (at a level equivalent to lecturer), and fellows (at a level equivalent to lecturer) to secure their first major element of research support funding.
Grants are available to NHS and academic researchers for specific research projects that involve the application of basic and/or clinical science to anaesthesia, critical care or pain management.
This ongoing call seeks to fund high-quality research within specific gaps in the NIHR Public Health Research (PHR) portfolio. Commissioned calls against which NIHR has failed to fund sufficient research will remain open within this call in order to stimulate the required research activity.
PHR programme funds research to generate evidence to inform the delivery of non-NHS interventions intended to improve the health of the public and reduce inequalities in health.
Provides funding over three to four years to support the creation and operation of virtual centres of excellence that bring together interdisciplinary experts working on issues of strategic relevance to people with cystic fibrosis.
The Institute's postdoctoral career development fellowships provide an opportunity for exceptional postdoctoral clinicians to consolidate their research experience. Postdoctoral clinicians can apply for funding to spend one year full-time or two years part-time working in a Crick research group, on a project agreed between the fellow and the Crick group leader. The aim of the scheme is to: Foster long-term clinical links and collaborations.Provide clinicians with a postdoctoral extension of their research experience, and with scientific networking, training and career development opportunities at the Crick.Provide a platform from which fellows may apply for external funding such as clinician scientist fellowships, to be held at the Crick or elsewhere.
The Patient Care Pioneer Award provides funding specifically for patient-focused applied research which has direct relevance to leukaemia and/or related diseases. The funding supports innovative patient-centred projects that aim to explore new practical approaches to improve treatment/post-treatment, care, and quality of life for individuals living with leukaemia.
The fellowships scheme provides support for researchers wishing to undertake independent research and gain leadership skills. They support the transition of early stage researchers to fully independent research leaders.
Grants available to academic researchers working to advance new gene therapy technologies, ranging from preclinical research through to early clinical studies, with additional funding available to successful projects to enable them to use the manufacturing capabilities of the Innovation Hubs for Gene Therapies.
Small grants for UK researchers and teams carrying out early stage innovation on the prevention of gynaecological cancers (womb, ovarian, cervical, vulval and vaginal).
THRIVE aims to accelerate the translation of healthcare innovations tackling health inequalities from bench to bed, speed up patient benefit and concurrently expand the entrepreneurial mindset of researchers and clinicians.
AI for health: future predictive research for a healthier population, covering novel AI, automation and data science techniques to creating a healthier state. This includes advanced diagnostics, visualisation of invisible disease lesions and prediction and prevention of lifestyle-related diseases, frailty and early detection of cognitive decline.
Funding to support collaborative research and development of medical devices, in vitro diagnostic devices and high-impact patient-focused digital health technologies for use in the NHS or social care system in the UK.
This Funding Opportunity Announcement encourages applications that investigate the biology and underlying mechanisms of bladder cancer. Bladder cancer is a significant health problem globally. Because of the high incidence and frequent tumour recurrence, bladder cancer exacts an outsized medical burden. While recent progress has been made in the molecular profiling of bladder cancers and identification of mutated genes, relatively little is known regarding the molecular mechanisms driving initiation, progression and malignancy of bladder cancer. Furthermore, understanding of the biological processes of the normal bladder at the molecular, cell and organ levels is limited. Fundamental knowledge of how molecular and cellular functions of the bladder are altered in cancer will aid understanding of bladder cancer biology and contribute to the future development of new interventions.
Grants to support early career researchers in the UK undertaking translational or proof of concept research in any area of gastroenterology (including pancreatology and hepatology).
Funding available to UK organisations and educational establishments for the funding of capital infrastructure in the fields of science and medicine, health, education and the arts and humanities.
Doctoral funding programme for research institutions in the UK to host PhD research projects focusing on the molecular and cellular basis of retinal degeneration.
HIS offers research grants to support research projects in the field of healthcare-associated infections (HCAIs) and infection prevention and control in the UK or Ireland. The thematic focus is on translational research.
This award aims to accelerate and drive forward the development of novel drugs for the treatment of Parkinson's. The initiative should provide researchers with the opportunity to generate essential data and help bridge the gaps needed to get their projects/compounds ready to enter full scale drug discovery with an industry partner.
Fellowships are available for European and Japanese researchers from any discipline to carry out a research visit in either Japan or Europe, respectively.
This Funding Opportunity Announcement (FOA) supports discrete, well-defined projects in any area of cancer research using the National Institutes of Health R03 small grant mechanism. The National Institutes of Health R03 small grant mechanism supports discrete, well-defined projects that realistically can be completed in two years and that require limited levels of funding. Examples of the types of projects that the R03 grant mechanism include, but are not limited to, the following: Pilot or feasibility studies.Secondary analysis of existing data.Small, self-contained research projects.Development of research methodology.Development of new research technology.
This Notice of Funding Opportunity (NOFO) invites mechanistic research that aims to understand how and why expectancy effects occur in a cancer context, elucidate their role in cancer symptom management, and identify patients, symptoms, cancer sites and contexts in which expectancy effects can be leveraged to improve cancer outcomes. Expectancies are defined in this context as beliefs about future outcomes, including one's response to cancer or cancer treatment. Expectancies can be evoked by social, psychological, environmental and systemic factors. Expectancy effects are the cognitive, behavioural and biological outcomes caused by expectancies. Expectancy effects can be generated by expectancies held by patients, clinicians, family members, caregivers and/or dyadic/social networks.
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) is inviting research projects that implement early phase (Phase 0, I and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of NCI's Division of Cancer Treatment and Diagnosis (DCTD) and Office of HIV and AIDS Malignancies (OHAM). The proposed project must involve at least one clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program, and/or the HIV and AIDS Malignancies Research Programs.
